1. Home
  2. |Professionals
  3. |Nate Young

Nate Young

Senior International Trade Specialist II
Senior International Trade Specialist II
bnlvdW5nQGNyb3dlbGwuY29t
VCard
VCard

Areas of Focus

Overview

Nate Young is a Senior International Trade Specialist in Crowell & Moring’s Washington, D.C. office. With nearly 20 years of expertise in national security and foreign policy, Nate provides clients compliance advice on the U.S. Export Administration Regulations and International Traffic in Arms Regulations (ITAR). Nate assists in obtaining necessary export authorizations, conducting analyses on emerging and critical technologies, managing jurisdiction and classification requests, and handling ITAR registration actions. Nate actively monitors export control developments and is a regular contributor to Crowell’s international trade blog.

In his previous roles, Nate spent several years leading high-level projects for the U.S. Department of Defense and global aerospace firms. At the State Department, he was pivotal as a Senior Defense Trade Analyst and Outreach Coordinator at the Directorate of Defense Trade Controls and helped shape foreign military sales policy at the Bureau of Political-Military Affairs. He also served overseas at U.S. embassies in Russia, the Philippines, and Kazakhstan, where he wrote cables on political and economic developments. He began his career as a Presidential Management Fellow focusing on civil nuclear cooperation and nonproliferation policy.

Career & Education

    • Department of State
      • Senior Defense Trade Analyst and Outreach Coordinator, Directorate of Defense Trade Controls, 2016–2019
      • Foreign Affairs Officer, Bureau of Western Hemisphere Affairs, Office of Brazil and the Southern Cone, 2015–2016
      • Political Officer, U.S. Embassy Manila, Philippines, 2013–2015
      • Foreign Affairs Officer, Bureau of Political-Military Affairs, Office of Regional Security and Arms Transfers, 2010–2013
      • Foreign Affairs Officer, Bureau of European and Eurasian Affairs, Office of Policy and Regional Affairs, 2006–2010
      • Foreign Affairs Officer, U.S. Embassy Moscow, Russia, and U.S. Embassy Almaty, Kazakhstan, 2005–2008
    • Department of State
      • Senior Defense Trade Analyst and Outreach Coordinator, Directorate of Defense Trade Controls, 2016–2019
      • Foreign Affairs Officer, Bureau of Western Hemisphere Affairs, Office of Brazil and the Southern Cone, 2015–2016
      • Political Officer, U.S. Embassy Manila, Philippines, 2013–2015
      • Foreign Affairs Officer, Bureau of Political-Military Affairs, Office of Regional Security and Arms Transfers, 2010–2013
      • Foreign Affairs Officer, Bureau of European and Eurasian Affairs, Office of Policy and Regional Affairs, 2006–2010
      • Foreign Affairs Officer, U.S. Embassy Moscow, Russia, and U.S. Embassy Almaty, Kazakhstan, 2005–2008

    • Johns Hopkins University, M.A., School of Advanced International Studies (SAIS), international relations & economics
    • Northwestern University, B.A.,
      history and Slavic Studies
    • Johns Hopkins University, M.A., School of Advanced International Studies (SAIS), international relations & economics
    • Northwestern University, B.A.,
      history and Slavic Studies

    • Russian
    • Russian

Nate's Insights

Client Alert | 5 min read | 04.07.26

Trump Administration Imposes Section 232 Tariffs on Patented Pharmaceutical Imports; Tiered Rate Structure Takes Effect Beginning July 31, 2026

On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962, as amended (19 U.S.C. § 1862), to impose tariffs on imports of patented pharmaceuticals, biologics, and associated ingredients into the United States.  The action affects pharmaceutical manufacturers, importers, and supply chain participants.   ...

View All Insights

Insights

Client Alert | 5 min read | 04.07.26

Trump Administration Imposes Section 232 Tariffs on Patented Pharmaceutical Imports; Tiered Rate Structure Takes Effect Beginning July 31, 2026

Blog Post | 04.02.26

EU Co-Legislators Agree on UCC Proposal

Blog Post | 03.31.26

Senate Committee Advances Bill to Shield U.S. Companies from Foreign Judgment Enforcement in the United States Relating to U.S. Sanctions Compliance

Blog Post | 03.02.26

OFAC Sanctions Rwanda’s Military

View All Insights

Practices

Nate's Insights

Client Alert | 5 min read | 04.07.26

Trump Administration Imposes Section 232 Tariffs on Patented Pharmaceutical Imports; Tiered Rate Structure Takes Effect Beginning July 31, 2026

On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962, as amended (19 U.S.C. § 1862), to impose tariffs on imports of patented pharmaceuticals, biologics, and associated ingredients into the United States.  The action affects pharmaceutical manufacturers, importers, and supply chain participants.   ...

View All Insights